[go: up one dir, main page]

GB201514649D0 - 2-Sulfonylpyrimidines - Google Patents

2-Sulfonylpyrimidines

Info

Publication number
GB201514649D0
GB201514649D0 GBGB1514649.1A GB201514649A GB201514649D0 GB 201514649 D0 GB201514649 D0 GB 201514649D0 GB 201514649 A GB201514649 A GB 201514649A GB 201514649 D0 GB201514649 D0 GB 201514649D0
Authority
GB
United Kingdom
Prior art keywords
sulfonylpyrimidines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1514649.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Research Council filed Critical Medical Research Council
Priority to GBGB1514649.1A priority Critical patent/GB201514649D0/en
Publication of GB201514649D0 publication Critical patent/GB201514649D0/en
Priority to PCT/GB2016/052544 priority patent/WO2017029498A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/38—One sulfur atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB1514649.1A 2015-08-18 2015-08-18 2-Sulfonylpyrimidines Ceased GB201514649D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1514649.1A GB201514649D0 (en) 2015-08-18 2015-08-18 2-Sulfonylpyrimidines
PCT/GB2016/052544 WO2017029498A1 (en) 2015-08-18 2016-08-17 2-sulfonylpyrimidines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1514649.1A GB201514649D0 (en) 2015-08-18 2015-08-18 2-Sulfonylpyrimidines

Publications (1)

Publication Number Publication Date
GB201514649D0 true GB201514649D0 (en) 2015-09-30

Family

ID=54258778

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1514649.1A Ceased GB201514649D0 (en) 2015-08-18 2015-08-18 2-Sulfonylpyrimidines

Country Status (2)

Country Link
GB (1) GB201514649D0 (en)
WO (1) WO2017029498A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11913077B2 (en) 2018-03-09 2024-02-27 Texas Tech University System Compositions and methods for the diagnosis and treatment of ALT cancer
TW202528348A (en) * 2023-10-31 2025-07-16 大陸商山東博安生物技術股份有限公司 Blocking antibodies against gipr and their antibody-drug conjugates
CN118496167B (en) * 2024-05-09 2025-10-31 西北师范大学 2-Sulfonyl pyrimidine-4-amide compound and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3173080D1 (en) * 1980-01-10 1986-01-16 Nyegaard & Co As Pyrimidine-2-sulphides and their s-oxides for use in medicine, pharmaceutical compositions containing them, processes for their preparation and such compounds when novel per se
WO2008118626A2 (en) * 2007-03-08 2008-10-02 Burnham Institute For Medical Research Inhibitors of jnk and methods for identifying inhibitors of jnk

Also Published As

Publication number Publication date
WO2017029498A1 (en) 2017-02-23

Similar Documents

Publication Publication Date Title
DK3389557T3 (en) Transseptalt leveringssystem
DK3320033T3 (en) Polyethylenterephthalat-depolymerisering
DK3256579T5 (en) Cysteinprotease
DK3250592T3 (en) Anti-transthyretin-antistoffer
DK3298030T3 (en) Anti-cancerfusionspolypeptid
DK3373882T3 (en) Patientisolator
GB201500806D0 (en) Aerosol-gnerating aticle
DK3336185T3 (en) Antistof
DK3390996T3 (en) Trykbart tids-temperaturindikatorsystem
DK3380145T3 (en) Injektionsapparat
GB201501723D0 (en) Winics
DK3324768T3 (en) Tørdragt
AU361999S (en) Ballustrade
PL3124119T3 (en) Degerminator
DK3133099T3 (en) Polymermodificeret polyoldispersion
IL254978B (en) 2-thiopyrimidinones
DK3242882T3 (en) Cgrp-antagonistpeptider
GB201514649D0 (en) 2-Sulfonylpyrimidines
DK3250312T3 (en) Urea-metalnitrat-scr-system
AU5516P (en) LEP08 Lepidosperma squamatum
AU5511P (en) PTK647 Epichloe coenophiala
AU366552S (en) Nutblock
AU367131S (en) USB-charger
PL3365601T3 (en) Crematoria
AU365008S (en) Playsuit

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)